Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
TAVI, or the Transcatheter Aortic Valve Implantation, is currently the newest minimally invasive procedure for aortic stenosis in healthcare. Very simply, the procedure replaces the old, diseased aortic valve with a new one. The implantation of the new valve is done without the need to open the heart completely, thereby drastically reducing the risk of post-procedural complications. This procedure is a boon for senior people with co-morbidities like diabetes and hypertension or who have previously undergone an open-heart surgery. It also has a shorter recovery time, which means that patients are able to go back to their daily lives much faster. The ultimate goal of the TAVI is to increase the patient's lifespan with a remarkable improvement in the quality of life.
This involves a large incision down the length of the chest. The TAVI procedure uses a catheter, which is a thin, flexible tube introduced through a small incision, usually in the groin. The catheter is guided to the heart using X-ray imaging techniques called fluoroscopy. The medical team pre-determines the pathway of the catheter before the procedure to avoid any unnecessary complications and issues. This methodology opens up the possibility of fixing aortic stenosis in senior citizens, which may not have been possible earlier. Since there is no need for an extended hospital stay, patients could have the procedure one day and leave the hospital within the next 48 hours.
Now, advancements in TAVI technology mark a significant improvement in treating aortic stenosis. The benefits greatly outweigh the risks, with its minimally invasive nature, quick recovery time, and lowered chances of post-surgical complications. TAVI is set to play an even more significant role in treating aortic heart valve disease, which can help hundreds of senior citizens live longer and healthier lives.